addus homecare corp - ADUS

ADUS

Close Chg Chg %
107.39 -0.81 -0.75%

Closed Market

106.58

-0.81 (0.75%)

Volume: 201.50K

Last Updated:

Jan 2, 2026, 4:00 PM EDT

Company Overview: addus homecare corp - ADUS

ADUS Key Data

Open

$108.00

Day Range

105.21 - 108.88

52 Week Range

88.96 - 136.72

Market Cap

$1.98B

Shares Outstanding

18.48M

Public Float

18.00M

Beta

0.92

Rev. Per Employee

N/A

P/E Ratio

22.99

EPS

$4.74

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

152.41K

 

ADUS Performance

1 Week
 
-3.25%
 
1 Month
 
-5.84%
 
3 Months
 
-7.21%
 
1 Year
 
-14.46%
 
5 Years
 
-8.98%
 

ADUS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 13
Full Ratings ➔

About addus homecare corp - ADUS

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as related services for its families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after hospitalization and include skilled nursing and physical, occupational, and speech therapy. The company was founded 1979 and is headquartered in Frisco, TX.

ADUS At a Glance

Addus HomeCare Corp.
6303 Cowboys Way
Frisco, Texas 75034
Phone 1-469-535-8200 Revenue 1.15B
Industry Medical/Nursing Services Net Income 73.60M
Sector Health Services 2024 Sales Growth 9.063%
Fiscal Year-end 12 / 2025 Employees 49,703
View SEC Filings

ADUS Valuation

P/E Current 22.986
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 29.601
Price to Sales Ratio 1.887
Price to Book Ratio 2.344
Price to Cash Flow Ratio 18.71
Enterprise Value to EBITDA 18.201
Enterprise Value to Sales 2.038
Total Debt to Enterprise Value 0.116

ADUS Efficiency

Revenue/Employee 23,229.966
Income Per Employee 1,480.756
Receivables Turnover 8.536
Total Asset Turnover 0.928

ADUS Liquidity

Current Ratio 1.67
Quick Ratio 1.67
Cash Ratio 0.635

ADUS Profitability

Gross Margin 31.309
Operating Margin 10.024
Pretax Margin 8.605
Net Margin 6.374
Return on Assets 5.914
Return on Equity 8.776
Return on Total Capital 5.918
Return on Invested Capital 7.005

ADUS Capital Structure

Total Debt to Total Equity 28.143
Total Debt to Total Capital 21.962
Total Debt to Total Assets 18.651
Long-Term Debt to Equity 26.824
Long-Term Debt to Total Capital 20.933
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Addus Homecare Corp - ADUS

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
864.50M 951.12M 1.06B 1.15B
Sales Growth
+13.04% +10.02% +11.31% +9.06%
Cost of Goods Sold (COGS) incl D&A
590.75M 660.74M 730.10M 793.11M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
14.49M 14.06M 14.13M 13.53M
Depreciation
5.99M 6.86M 7.03M 6.60M
Amortization of Intangibles
8.50M 7.20M 7.10M 6.93M
COGS Growth
+7.58% +11.85% +10.50% +8.63%
Gross Income
273.75M 290.38M 328.55M 361.49M
Gross Income Growth
+26.93% +6.07% +13.15% +10.03%
Gross Profit Margin
+31.67% +30.53% +31.03% +31.31%
2021 2022 2023 2024 5-year trend
SG&A Expense
186.32M 210.97M 231.68M 245.76M
Research & Development
- - - -
-
Other SG&A
186.32M 210.97M 231.68M 245.76M
SGA Growth
+10.20% +13.23% +9.82% +6.08%
Other Operating Expense
- - - -
-
Unusual Expense
21.50M 10.67M 5.91M 16.77M
EBIT after Unusual Expense
65.94M 68.74M 90.96M 98.97M
Non Operating Income/Expense
268.00K 341.00K 1.48M 8.12M
Non-Operating Interest Income
268.00K 341.00K 1.48M 4.39M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
5.81M 8.91M 11.11M 7.73M
Interest Expense Growth
+82.06% +53.41% +24.69% -30.38%
Gross Interest Expense
5.81M 8.91M 11.11M 7.73M
Interest Capitalized
- - - -
-
Pretax Income
60.40M 60.17M 81.33M 99.35M
Pretax Income Growth
+44.00% -0.38% +35.16% +22.17%
Pretax Margin
+6.99% +6.33% +7.68% +8.60%
Income Tax
15.27M 14.15M 18.81M 25.75M
Income Tax - Current - Domestic
7.00M 10.16M 15.98M 12.53M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
8.27M 3.98M 2.83M 13.22M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
45.13M 46.02M 62.52M 73.60M
Minority Interest Expense
- - - -
-
Net Income
45.13M 46.02M 62.52M 73.60M
Net Income Growth
+36.20% +1.99% +35.83% +17.73%
Net Margin Growth
+5.22% +4.84% +5.91% +6.37%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
45.13M 46.02M 62.52M 73.60M
Preferred Dividends
- - - -
-
Net Income Available to Common
45.13M 46.02M 62.52M 73.60M
EPS (Basic)
2.8675 2.9018 3.9082 4.3278
EPS (Basic) Growth
+34.98% +1.20% +34.68% +10.74%
Basic Shares Outstanding
15.74M 15.86M 16.00M 17.01M
EPS (Diluted)
2.8091 2.8444 3.8328 4.2346
EPS (Diluted) Growth
+35.28% +1.26% +34.75% +10.48%
Diluted Shares Outstanding
16.06M 16.18M 16.31M 17.38M
EBITDA
101.93M 93.47M 111.00M 129.26M
EBITDA Growth
+73.83% -8.30% +18.75% +16.46%
EBITDA Margin
+11.79% +9.83% +10.48% +11.20%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 143.455
Number of Ratings 13 Current Quarters Estimate 1.569
FY Report Date 03 / 2026 Current Year's Estimate 6.851
Last Quarter’s Earnings 1.72 Median PE on CY Estimate N/A
Year Ago Earnings 6.193 Next Fiscal Year Estimate 7.436
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 9 12 9
Mean Estimate 1.57 1.67 6.85 7.44
High Estimates 1.62 1.74 7.01 7.67
Low Estimate 1.47 1.59 6.75 7.20
Coefficient of Variance 2.88 2.49 1.23 2.25

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 10 10 10
OVERWEIGHT 1 1 1
HOLD 1 1 0
UNDERWEIGHT 0 0 0
SELL 1 1 1
MEAN Overweight Overweight Buy

Insider Actions for Addus Homecare Corp - ADUS

Date Name Shares Transaction Value
Nov 21, 2025 Darby Anderson EVP, Chief Govt Rel Officer 64,144 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $22.7 per share 1,456,068.80
Nov 21, 2025 Darby Anderson EVP, Chief Govt Rel Officer 44,144 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $109 per share 4,811,696.00
Nov 21, 2025 Darby Anderson EVP, Chief Govt Rel Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 28, 2025 Robby Stevenson EVP & Chief HR Officer 12,812 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.9 per share 1,279,918.80
Feb 28, 2025 R. Dirk Allison CEO and Chairman; Director 102,961 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.98 per share 10,294,040.78
Feb 28, 2025 W. Bradley Bickham President and COO 51,505 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.74 per share 5,137,108.70
Feb 28, 2025 David Tucker EVP / Chief Strategy Officer 11,138 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.77 per share 1,111,238.26
Feb 28, 2025 Michael Wattenbarger EVP/Chief Information Officer 9,841 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.71 per share 981,246.11
Feb 28, 2025 Monica S. Raines EVP/CCO and Quality Officer 14,882 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.73 per share 1,484,181.86
Feb 28, 2025 Cliff Blessing EVP/Chief Development Officer 10,579 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.81 per share 1,055,889.99
Feb 28, 2025 Sean Gaffney EVP / Chief Legal Officer 18,179 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.84 per share 1,814,991.36
Feb 28, 2025 Brian W. Poff EVP/Chief Financial Officer 32,969 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $99.88 per share 3,292,943.72
Feb 27, 2025 David Tucker EVP/Chief Strategy Officer 10,497 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $85.96 per share 902,322.12
Feb 27, 2025 David Tucker EVP / Chief Strategy Officer 8,527 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $133.05 per share 1,134,517.35
Feb 27, 2025 David Tucker EVP / Chief Strategy Officer 8,345 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $134.05 per share 1,118,647.25
Feb 27, 2025 David Tucker EVP / Chief Strategy Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2025 David Tucker EVP / Chief Strategy Officer 12,473 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $133 per share 1,658,909.00
Feb 27, 2025 David Tucker EVP / Chief Strategy Officer 10,497 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $133.89 per share 1,405,443.33
Feb 27, 2025 David Tucker EVP / Chief Strategy Officer 12,500 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 26, 2025 Sean Gaffney EVP / Chief Legal Officer 18,658 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $108.18 per share 2,018,422.44

Addus Homecare Corp in the News